On Friday, Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) opened lower -7.02% from the last session, before settling in for the closing price of $1.21. Price fluctuations for RVPH have ranged from $0.60 to $6.03 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 41.33% at the time writing. With a float of $28.50 million, this company’s outstanding shares have now reached $33.44 million.
Let’s determine the extent of company efficiency that accounts for 15 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Reviva Pharmaceuticals Holdings Inc (RVPH) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Reviva Pharmaceuticals Holdings Inc is 14.79%, while institutional ownership is 30.43%.
Reviva Pharmaceuticals Holdings Inc (RVPH) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.35 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.37) by 0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.25 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 41.33% per share during the next fiscal year.
Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) Trading Performance Indicators
Check out the current performance indicators for Reviva Pharmaceuticals Holdings Inc (RVPH). In the past quarter, the stock posted a quick ratio of 0.39.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.11, a number that is poised to hit -0.22 in the next quarter and is forecasted to reach -0.84 in one year’s time.
Technical Analysis of Reviva Pharmaceuticals Holdings Inc (RVPH)
Looking closely at Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH), its last 5-days average volume was 1.67 million, which is a jump from its year-to-date volume of 0.38 million. As of the previous 9 days, the stock’s Stochastic %D was 55.11%. Additionally, its Average True Range was 0.15.
During the past 100 days, Reviva Pharmaceuticals Holdings Inc’s (RVPH) raw stochastic average was set at 54.13%, which indicates a significant increase from 42.78% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 148.18% in the past 14 days, which was higher than the 133.10% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2147, while its 200-day Moving Average is $2.0070. However, in the short run, Reviva Pharmaceuticals Holdings Inc’s stock first resistance to watch stands at $1.2130. Second resistance stands at $1.3009. The third major resistance level sits at $1.3620. If the price goes on to break the first support level at $1.0640, it is likely to go to the next support level at $1.0029. Should the price break the second support level, the third support level stands at $0.9150.
Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) Key Stats
There are currently 33,441K shares outstanding in the company with a market cap of 34.98 million. Presently, the company’s annual sales total 0 K according to its annual income of -39,260 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -7,860 K.
